Istvan Enyedy

Istvan Enyedy is a highly experienced professional in computational chemistry, currently serving as Senior Director of Computational Chemistry at Third Harmonic Bio since October 2024, and as an Adjunct Professor at the University of Pittsburgh School of Pharmacy since May 2018. Previous roles include Senior Principal Scientist at UCB, Senior Director Computational Chemistry at Theseus Pharmaceuticals, and Director Computational Chemistry at Black Diamond Therapeutics, where significant contributions included the development of a selective compound with superior efficacy. Istvan's extensive background encompasses over a decade in leadership and scientific expertise at Biogen, Novartis Institutes for BioMedical Research, and Bayer HealthCare, contributing to the successful design of multiple drug candidates and collaborations with leading organizations. Educational qualifications include postdoctoral training in Computer-Aided Drug Design from Georgetown University Medical Center and a PhD in Chemistry from The Catholic University of America.